Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7295 p471
17 April 2004

This article
Reprint   Photocopy

PDF 65K, Acrobat Reader

Letters

· Methadone
· Electronic prescribing
· Drug nomemclature
· Community pharmacy
· Cod liver oil


Letters to the Editor

Electronic prescribing

11

Electronic prescribing is not a holy grail

From Mr R. A. Forde, MRPharmS

I would like to correct some inaccuracies portrayed in a recent Broad spectrum article about e-prescribing (PJ, 3 April, p412).

e-Prescribing has not been sidelined by the NHS IT agenda. It is part of the core product definition signed up to by local service providers (LSPs). Due to its nature, roll-out of e-prescribing may be delayed within the overall electronic prescription record development, but it is not sidelined. Examples of successful, general roll-outs of e-prescribing are not an elusive holy grail. I will cite Queen’s Hospital Burton-on-Trent, Liverpool Women’s Hospital, and Sunderland City Hospitals (which has rolled out inpatient e-prescribing to over 30 wards in just under 15 months). In the next few weeks, my hospital will start a full roll-out through surgery and medicine after completing a successful pilot and project reconfiguration. These are real examples that have not been publicised greatly because the focus has been on delivery and modest achievement.

If the article’s author believes that JAC is “the one IT supplier that appears to be making significant progress with the development of an electronic prescribing solution”, he is mistaken. All of the above-mentioned hospitals work with a total EPR supplier, Meditech, and although the system has had its critics from hospitals that do not use it, there is little substantiated criticism from those that do.

Equally, there is no definition of what e-prescribing is to entail in its entirety. For example, should e-prescribing interact with a pathology module? Even successful hospitals do not have 100 per cent electronic prescriptions: there is a manual interface with the stock control system. It will always be difficult to proclaim “significant progress” until one knows what one is progressing towards and such declarations should be treated with scepticism.

For those IT professionals who perceive e-prescribing as being difficult to implement, I advise them to speak to those who have done it. What they will find is that e-prescribing requires a lot of hard work, dedication from a committed team of staff, and good project management. But it is not impossible; it can be done safely and it is not a holy grail.

Robert Forde
Meditech Pharmacy and Electronic Prescribing Manager
Countess of Chester NHS Foundation Trust

Send your letter to The Editor

Previous Topic (Methadone)
Next Topic (Drug nomenclature)

Back to Top


©The Pharmaceutical Journal